HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% Drug Patent Profile
✉ Email this page to a colleague
When do Heparin Sodium 25,000 Units In Sodium Chloride 0.45% patents expire, and when can generic versions of Heparin Sodium 25,000 Units In Sodium Chloride 0.45% launch?
Heparin Sodium 25,000 Units In Sodium Chloride 0.45% is a drug marketed by Fresenius Kabi Usa, B Braun, and Hospira. and is included in three NDAs.
The generic ingredient in HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Sodium 25,000 Units In Sodium Chloride 0.45%
A generic version of HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%?
- What are the global sales for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%?
- What is Average Wholesale Price for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%?
Summary for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 6 |
Clinical Trials: | 98 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% at DailyMed |
![HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% drug patent expirations Drug patent expirations by year for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%](/p/graph/s/t/HEPARIN_SODIUM_25,000_UNITS_IN_SODIUM_CHLORIDE_0.45%-patent-expirations.png)
Recent Clinical Trials for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prevail Infoworks, Inc | Phase 2 |
Vaneltix Pharma, Inc. | Phase 2 |
The First Affiliated Hospital with Nanjing Medical University | N/A |
See all HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% clinical trials
Pharmacology for HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Drug Class | Anti-coagulant Unfractionated Heparin |